Extended Data Fig. 1: Kaplan-Meier plot of overall survival.
The 12-month OS estimates were 63% (90% CI: 52%–72%) and 57% (38%–71%) for the combination therapy versus ipilimumab alone groups, respectively.
Extended Data Fig. 1: Kaplan-Meier plot of overall survival. | Nature Medicine
